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Abstract 
Short peptides have been identified from amyloidogenic proteins that form amyloid 
fibrils in isolation. The hexapeptide stretch 21DIDLHL26 has been shown to be important in the 
self-assembly of the Src homology 3 (SH3) domain of p85α subunit of bovine 
phosphatidylinositol-3-kinase (PI3-SH3). The SH3 domain of chicken brain α-spectrin, which is 
otherwise non-amyloidogenic, is rendered amyloidogenic if 22EVTMKK27 is replaced by 
DIDLHL. In this article, we describe the aggregation behaviour of DIDLHL-COOH and 
DIDLHL-CONH2. Our results indicate that DIDLHL-COOH and DIDLHL-CONH2 aggregate to 
form spherical structures at pH 5 and 6. At pH 5, in the presence of mica, DIDLHL-CONH2 
forms short fibrous structures. The presence of NaCl along with mica results in fibrillar 
structures. At pH 6, DIDLHL-CONH2 forms largely spherical aggregates. Both the peptides are 
unstructured in solution but adopt β-conformation on drying. The aggregates formed by 
DIDLHL-COOH and DIDLHL-CONH2 are formed during drying process and their structures 
are modulated by the presence of mica and salt. Our study suggests that a peptide need not have 
intrinsic amyloidogenic propensity to facilitate the self-assembly of the full-length protein. The 
propensity of peptides to form self-assembled structures that are non-amyloidogenic could be 
important in potentiating the self-assembly of full-length proteins into amyloid fibrils. 
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1. Introduction 
Peptides with highly variable lengths and amino acid sequences have been observed to 
form amyloid fibrils (Jarvis et al. 1993; Tenidis et al. 2000; Lopez De La Paz et al. 2002; Reches 
et al. 2002; Tjernberg et al. 2002; Jones et al. 2003; Goux et al. 2004). While many of these 
peptides are segments of proteins that form fibrils in vivo and are related to pathogenesis (Jarvis 
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et al. 1993; Tenidis et al. 2000; Reches et al. 2002; Goux et al. 2004), others are unrelated to 
pathogenesis (Fezoui et al. 2000; Lopez De La Paz et al. 2002; Tjernberg et al. 2002). The 
conditions under which peptides form fibrils vary considerably with respect to pH, ionic 
strength, temperature, aggregation times as well as the presence of organic solvents (Burdick et 
al. 1992; Harper et al. 1999; Thompson et al. 2000; Goux et al. 2004; Chaudhary et al. 2008; 
Chaudhary et al. 2009). Amyloid formation by peptides and proteins has also been observed on 
solid substrates such as mica or quartz (Zhu et al. 2002; Losic et al. 2006). 
The amyloid forming ability of peptides that are segments of amyloid-forming proteins 
has been the subject of extensive investigation (Tenidis et al. 2000; Kozhukh et al. 2002; Reches 
et al. 2002; Jones et al. 2003; Goux et al. 2004; Ivanova et al. 2006; Thompson et al. 2006). It 
appears that the peptide segments, in isolation, do have the ability to form fibrils that are very 
similar to the fibrils formed by the parent proteins. These peptide fibrils have the conformational 
features of β-structure that are observed in protein fibrils (Giasson et al. 2001; Iconomidou et al. 
2001; Iconomidou et al. 2000; Fandrich et al. 2003; Jones et al. 2003). 
The Src homology 3 (SH3) domain of p85α subunit of bovine phosphatidylinositol-3-
kinase (PI3-SH3) forms amyloid fibrils at acidic pH (pH 2.0), while the SH3 domain of chicken 
brain -spectrin (SPC-SH3), which shares same fold and 24% sequence identity with PI3-SH3, 
does not form fibrils under these conditions (Guijarro et al. 1998; Ventura et al. 2004). At pH 
2.0, the PI3-SH3 domain is partially denatured following which the domain self-assembles into 
amyloid-like fibrils. The presence of extensive native-like interactions in SPC-SH3 under acidic 
pH, as suggested by solution NMR studies (Kortemme et al. 2000), may account for its inability 
to form amyloid fibrils under these conditions. Replacing a six-amino-acid stretch 
(22EVTMKK27) in SPC-SH3 with PI3-SH3 hexapeptide 21DIDLHL26, comprising residues in the 
diverging turn and adjacent RT loop, confers amyloidogenicity to SPC-SH3 (Ventura et al. 
2004). Replacement of residues HL in the DIDLHL segment of PI3-SH3 by consensus residues 
KK renders the domain non-amyloidogenic, indicating the importance of the DIDLHL sequence 
in conferring amyloidogenicity to the domain. Interestingly, both amyloidogenic and non-
amyloidogenic forms of PI3-SH3 are denatured to similar extent at pH 2.0 (Ventura et al. 2004). 
This suggests that the sequence DIDLHL does not affect the stability of SH3 domain in 
conferring amyloidogenicity to it. In this study, we have investigated the aggregation behavior of 
NH2DIDLHLCONH2 (D-am) and NH2DIDLHLCOOH (D-ac) under various conditions. 
2. Materials and methods 
Fmoc amino acids were purchased from Novabiochem AG (Switzerland) and Advanced 
ChemTech (Louisville, KY). Peptide synthesis resins, HMP (p-Hydroxymethylphenoxymethyl 
polystyrene resin) and PAL (5-(4-Aminomethyl-3,5-dimethoxyphenoxy)valeric acid resin) were 
purchased from Applied Biosystems (Foster City, CA) and Advanced ChemTech (Louisville, 
KY), respectively. Thioflavin T was purchased from Sigma. 
2.1 Peptide synthesis 
The peptides NH2DIDLHLCONH2 (D-am) and NH2DIDLHLCOOH (D-ac) were 
synthesized using standard Fmoc chemistry (Atherton 1989). The synthesized peptides were 
cleaved from the resin and deprotected using a mixture containing 82.5% trifluoroacetic acid 
(TFA), 5% phenol, 5% H2O, 5% thioanisole and 2.5% ethanedithiol for 12–15 h at room 
temperature (King et al. 1990). The peptides were precipitated in ice-cold diethyl ether. The 
peptides were dissolved in deionized water and purified on Hewlett Packard 1100 series HPLC 
instrument on a reversed-phase C18 Bio-Rad column using a linear gradient of H2O-acetonitrile, 
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both containing v/v 0.1% TFA. Purified peptides were characterized using matrix-assisted laser 
desorption ionization-time-of-flight (MALDI-TOF) mass spectrometry on a Voyager DE STR 
mass spectrometer (PerSeptive Biosystems, Foster city, CA) in the Proteomics Facility at the 
Centre for Cellular and Molecular Biology, India. The spectra of the peptides showed m/z values 
of 724.26 for D-am (calculated mass: 723.80 Da) and 725.24 for D-ac (calculated mass: 724.80 
Da). Stock solutions of the peptides were prepared in deionized water and concentrations were 
determined using Waddell’s method of protein concentration estimation (Waddell 1956; Wolf 
1983). 
2.2 Aggregation reactions 
Aggregation reactions at 200 µM peptide concentration were set up for both D-am and D-
ac in 10 mM acetate buffer, pH 5, and 10 mM phosphate buffer, pH 6, with/without 100 mM 
NaCl and with/without freshly cleaved mica piece at 37°C for 5 days. These pH values were 
chosen for the studies after screening the pH range of 2–12 for aggregation. Samples having 
mica were prepared as follows: after preparing the peptide solution in the desired buffer, a 
rectangular piece of mica was immediately dropped into the sample tube. Both the surfaces of 
the mica piece were freshly peeled prior to dropping it in the sample tube. Aggregation of all the 
samples was studied using atomic force microscopy. 
2.3 Atomic force microscopy 
Aggregation reaction samples were diluted in deionized water and immediately deposited 
on freshly cleaved surface of mica sheets (1 µg peptide was deposited) and allowed to dry in 
air. Atomic force microscopy (AFM) images were acquired in an atomic force microscope 
(Multimode, Digital Instruments, Santa Barbara, CA) using tapping mode. A silicon nitride 
probe was oscillated at 275–310 kHz and images were collected at an optimized scan rate. 
Analysis was done using Nanoscope ® III 5.30 r1. All the images are second order flattened and 
presented in the height mode. Height analysis was done using ‘Section’ tool present in the 
Nanoscope software. 512×512 points were acquired for each AFM image. The individual images 
were re-sized to obtain the desired resolution of 300 dots per inch. 
2.4 Circular dichroism 
Circular dichroism (CD) spectra were recorded on Jasco J-715 spectropolarimeter.  Far-
UV spectra (195–250 nm) were recorded for 120 µM peptide solutions in 10 mM actetate buffer, 
pH 5, and 10 mM phosphate buffer, pH 6, with/without 100 mM NaCl in 0.1 cm path length cell 
using a step size of 0.2 nm, band width of 1 nm, and scan rate of 100 nm/min.  The spectra were 
recorded by averaging eight scans and corrected by subtracting the buffer spectra. 
 
2.5 Fourier transform infrared spectroscopy 
Fourier transform infrared spectra (FTIR) were recorded on a Bruker Alpha-E 
spectrometer with Eco attenuated total reflection (ATR) single reflection ATR sampling module 
equipped with ZnSe ATR crystal. Peptide solutions (200 µM) were prepared in deionized water 
without exchanging TFA counterions. Peptide solutions (20 µl) were spread out and dried as 
films on ZnSe crystal and ATR-FTIR spectra were recorded. Each spectrum is the average of 64 
FTIR spectra at a resolution of 4 cm−1. 
3. Results and discussion 
The peptide segment DIDLHL has been shown to promote the formation of amyloid 
fibrils in PI3-SH3 and α-spectrin-SH3 domains (Guijarro et al. 1998; Ventura et al. 2004). Two 
peptides, D-ac and D-am, were examined for their ability to form aggregates under different 
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conditions such as pH, salt concentration and the presence of mica. The aggregates were 
characterized by AFM. Along with the AFM images, a height profile of a line segment drawn on 
the figure is also shown. The height of one aggregate in each AFM figure has been indicated 
with black triangle. 
The aggregates of D-ac at pH 5 and 6, in the presence of salt and mica, were examined 
(figure 1). At pH 6, largely spherical aggregates (heights ~1–6 nm) are observed (figure 1A and 
B). A few linear fibrils (~2–3 nm thick, indicated by arrows) associated with spherical 
aggregates are also observed. The heights of the fibrils are indicated by black triangles. In the 
presence of mica, at pH 6, only spherical aggregates (~2–12 nm) are observed (figure 1C). At pH 
5, too, in the presence of 100 mM NaCl, only spherical aggregates (~2–10 nm) are observed 
(figure 1D). The presence of mica does not cause any significant change in the aggregates (data 
not shown).  
 The aggregates formed by D-am under different conditions were examined. At pH 5, D-
am forms spherical aggregates up to 35 nm in diameter (figure 2). An aggregate ~23 nm in 
height is labelled with the black triangle. The dragging of the aggregates towards right could 
arise from tip-sample interactions. In the presence of mica at pH 5, small fibrillar aggregates are 
observed (figure 3). Figure 3A shows presence of small fibrous structures (2–6 nm in thickness). 
In figure 3B, a mixture of very small aggregates, thin fibrils (<1–3 nm) and thicker fibrillar 
structures (3–6 nm, indicated by arrows) are observed. When NaCl is also present along with 
mica, fibrillar aggregates are observed (figure 4). The panels show images recorded from 4 
independently prepared samples. The fibrils show considerable polymorphism. The dimensions 
of the fibrils vary considerably (thickness ranging from 1–10 nm). Figure 4A–C shows fibers 
that appear similar to amyloid protofibrils in dimensions (heights ≤3.5 nm, lengths <1 µm). The 
fibrils in figure 4D vary in diameter from very thin to those typical of amyloid protofilaments 
and amyloid fibrils (~1–10 nm). 
The D-am aggregates obtained at pH 6 are shown in figure 5. The panels represent 
independent samples. Fibril formation was no longer discernible. Individual spheres, very small 
to very large (~3–50 nm) are observed (figure 5A and B). In one case, large oval egg-shaped 
structures (figure 5C) were observed. Even in the presence of either mica (figure 6A) or NaCl 
(figure 6B) during aggregation process, mostly spherical aggregates are observed with very few 
thin filamentous structures figure 6A). While aggregates with different morphologies were 
detected for D-am and D-ac by AFM, none of them caused any increase in Thioflavin T 
fluorescence (data not shown), indicating that the peptide sequences do not form mature amyloid 
fibrils under the conditions studied.  
 Amide I region in FTIR spectra is sensitive to secondary structures of proteins and 
peptides as it largely arises from C=O stretching vibrations with a small contribution from NH 
bending (Surewicz et al. 1993; Haris and Chapman 1995; Jackson and Mantsch 1995). The 
peptides were dried on ZnSe crystal from water and attenuated total reflectance-FTIR (ATR-
FTIR) spectra were recorded on dry peptide films to correlate the peptide secondary structures 
with self-assembled structures on mica (figure 7). Amide I absorption band centered at 1631 
cm−1 was observed for D-am (figure 7A), while D-ac amide I band was centered at 1637 cm−1 
(figure 7B). The amide I frequencies from 1625 to 1640 cm−1 correspond to β-sheet structure, 
while 1640–1648 cm−1 corresponds to unordered polypeptide chain (Jackson and Mantsch 1995). 
The data suggest that both D-am and D-ac adopt β-structure in the dried form. However, the 
amide I band of D-ac at 1637 cm−1 indicates more unordered component as compared with that 
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in D-am, which correlates with its lower propensity to form fibrillar structures. In solution, 
secondary structures at pH 5 and 6 with/without 100 mM NaCl were studied using CD 
spectroscopy. CD spectra of both the peptides are suggestive of unordered conformation 
irrespective of the presence or absence of NaCl (figure 8). These results clearly suggest that the 
peptides self-assemble by adopting β-conformation during drying process. 
 In vitro, proteins that form fibrils under disease conditions, as well as peptides with 
widely differing sequences, form fibrils and other aggregated structures that exhibit highly 
variable morphologies (Bauer et al. 1995; Kad et al. 2001; Lopez De La Paz et al. 2002; Goux et 
al. 2004; Goldsbury et al. 2005; Kardos et al. 2005; Petkova et al. 2005; Anderson et al. 2006; 
Paravastu et al. 2006). Even fibrils produced under single growth conditions display considerable 
variation in their morphologies from the same sample preparation (Jansen et al. 2005; Anderson 
et al. 2006). In the case of insulin and Aβ, spherical structures appear to precede fibril formation 
(Blackley et al. 2000; Goldsbury et al. 2005; Jansen et al. 2005). Thus, the process of mature 
fibril formation appears to proceed via several intermediate aggregates, which are not necessarily 
fibrillar. In fact, the initial structure need not even be a β-structure (Fezoui et al. 2000; Fandrich 
et al. 2001; von Bergen et al. 2005). A highly amyloidogenic peptide derived from the Aβ 
sequence has a polyproline II like structure (Gnanakaran et al. 2006). Short peptides, which are 
unlikely to adopt ordered secondary structure, have been shown to self-assemble into ordered 
aggregates (Gorbitz 2001; Reches and Gazit 2003; Reches and Gazit 2006). The peptide, Ac-
VYK-am, adopts random coil conformation as suggested by CD, and does not cause 
enhancement in ThT fluorescence (Goux et al. 2004). However, the peptide forms fibrillar 
aggregates as observed using electron microscopy (Goux et al. 2004). We find that fibrils were 
observed for D-am but not for D-ac. Fibrils were observed at pH 5 and non-fibrillar oligomeric 
structures were observed at pH 6. The pKa2 of histidine is 6.0. At pH 5, ~90% of the histidine 
would be positively charged. Therefore, D-ac would have a net charge of −1, while D-am would 
have net charge of 0. It appears that net charge on the peptide influences its self-association. 
Mica, which has a negatively charged surface, could interact with the peptide via electrostatic 
interactions. NaCl would shield any charge present on the peptide further driving its self-
association, probably through stabilization of hydrophobic interactions. 
 Our results with DIDLHL peptides indicate their propensities to form spherical 
aggregates as well as filamentous structures. However, we have not been able to observe the 
transformation of these soluble aggregates into insoluble amyloid fibril structures. Under the 
conditions of low pH, at which PI3-SH3 forms fibrils, the DIDLHL sequence might act as a 
facilitator that promotes the formation of fibrils with other regions of the protein, probably 
through charge compensation and hydrophobic interactions (von Bergen et al. 2001; Chiba et al. 
2003). Distal peptide sequences have been shown to facilitate amyloid formation in proteins such 
as β2-microglobulin (Ivanova et al. 2004). The ability to potentiate the formation of aggregates 
could be the reason for the induction of aggregation by DIDLHL in α-spectrin-SH3 domain, 
which, on its own, does not form fibrils (Kortemme et al. 2000). It has been observed that a 
single mutation can cause α-spectrin-SH3 domain to form fibrillar aggregates indicating that the 
protein could be prone to destabilization resulting in fibril formation (Morel et al. 2006). 
However, replacement of 25HL26 in PI3-SH3 with the consensus KK sequence does not affect its 
stability but renders it non-amyloidogenic. This suggests that the sequence, DIDLHL may not be 
required for the stability of the SH3 domain but is important for conferring amyloidogenicity to 
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it, further suggesting that the stretch might act as a facilitator in amyloid formation by interacting 
with other aggregation-prone stretches present in the domain. 
4. Conclusions 
 Our results with DIDLHL peptides indicate their ability to form spherical aggregates as 
well as filamentous structures. However, we have not been able to observe the formation of 
amyloid fibril structures. Although fibrillar structures were obtained for D-am at pH 5 in the 
presence of salt and mica, their amyloid nature is not confirmed. Amyloid fibrils cause 
enhancement in ThT fluorescence and their amide I band in FTIR spectra appear at ~1620–1629 
cm−1 (Tracz et al. 2004; Yamaguchi et al. 2005). Absence of these features suggests that the 
fibrils formed by D-am may not be classical amyloid-like. Formation of fibrils by only certain 
short peptide segments of amyloid forming proteins suggests an important role for such 
sequences in the formation of fibrils by the mature protein (Giasson et al. 2001; Kozhukh et al. 
2002; Jones et al. 2003). In several cases, changes in the sequence of these peptides abrogate 
fibril formation suggesting that the requirement may be stringent (von Bergen et al. 2000). Our 
results with DIDLHL suggest that it may not be necessary in all the cases for the peptide, 
presumed to play a role in amyloid formation, to form mature fibrils in isolation. The ability to 
aggregate, particularly to form aggregates of various morphologies, could be sufficient to induce 
fibril formation in the protein. In vivo, peptides and proteins are likely to encounter surfaces and 
interfaces which could modulate amyloid fibril formation as demonstrated for Aβ (Losic et al. 
2006) and recombinant amyloidogenic light chain variable domain (Zhu et al. 2002). Hence, 
self-assembly of peptides related to the process of amyloid formation at surfaces or interfaces 
could have physiological relevance. 
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Legends to figures 
Figure 1.  AFM imaging of D-ac samples obtained after incubating at pH 6 (A and B), pH 6 + 
mica (C), and pH 5 + 100 mM NaCl (D). Panel B is the ‘zoomed in’ region from panel A. 
Arrows indicate the fibrillar structures and are described in the text. Scale bars represent 1 µm. 
Figure 2.   AFM imaging of D-am sample incubated at pH 5. Scale bar represents 1 µm. 
Figure 3. AFM imaging of D-am samples incubated at pH 5 in the presence of mica. The panels 
represent independent samples. Arrows are described in the text. Scale bars represent 1 µm. 
Figure 4.  AFM imaging of D-am samples incubated at pH 5 in the presence of mica and 100 
mM NaCl. The panels represent images recorded for four independently prepared samples. Scale 
bars represent 1 µm. 
Figure 5. AFM imaging of D-am samples incubated at pH 6. The panels represent images 
recorded from independent samples. Scale bars represent 1 µm. 
Figure 6.  AFM imaging of D-am samples incubated at pH 6 in the presence of mica (A) and in 
the presence of 100 mM NaCl (B). Scale bars represent 1 µm. 
Figure 7.  ATR-FTIR spectra of Amide I region of D-am (A) and D-ac (B) after drying the 
peptides (4 nmol) from water.  
Figure 8. Far-UV CD spectra of D-am at pH 5 (A) and pH 6 (B) without (▬) and with (—) 100 
mM NaCl. Spectra of D-ac at pH 5 (C) and pH 6 (D) without (▬) and with (—) 100 mM NaCl. 
 








